Invesaro

Stocks BIO Earnings

Earnings

Bio-Rad Laboratories, Inc. (BIO) earnings

Quarterly results of Bio-Rad Laboratories, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when BIO files with the SEC.

Next earnings date

Bio-Rad Laboratories, Inc. is expected to report around February 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Bio-Rad Laboratories, Inc. reported revenue of $656.4M (+0.5% on the same quarter a year earlier) and net income of $458.6M.

Diluted earnings per share were $17.02.

Filed with the SEC on November 4, 2026.

Revenue by quarter
Q4 24: $667.5M $667.5M Q4 24Q1 25: $585.4M $585.4M Q1 25Q2 25: $651.6M $651.6M Q2 25Q3 25: $653M $653M Q3 25Q4 25: $693.2M $693.2M Q4 25Q1 26: $592.1M $592.1M Q1 26Q2 26: $651M $651M Q2 26Q3 26: $656.4M $656.4M Q3 26
Net income by quarter
Q4 24: -$715.8M -$715.8M Q4 24Q1 25: $64M $64M Q1 25Q2 25: $317.8M $317.8M Q2 25Q3 25: -$341.9M -$341.9M Q3 25Q4 25: $720M $720M Q4 25Q1 26: -$527.1M -$527.1M Q1 26Q2 26: $371.4M $371.4M Q2 26Q3 26: $458.6M $458.6M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$656.4M+0.5%$458.6M$17.02
Q2 FY2026June 30, 2026$651M-0.1%$371.4M$13.85
Q1 FY2026March 31, 2026$592.1M+1.1%-$527.1M-$19.55
Q4 FY2025December 31, 2025$693.2M+3.9%$720M-
Q3 FY2025September 30, 2025$653M--$341.9M-$12.70
Q2 FY2025June 30, 2025$651.6M-$317.8M$11.67
Q1 FY2025March 31, 2025$585.4M-$64M$2.29
Q4 FY2024December 31, 2024$667.5M--$715.8M-$25.57

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Bio-Rad Laboratories, Inc.'s next earnings date?

Bio-Rad Laboratories, Inc. is expected to report around February 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Bio-Rad Laboratories, Inc.'s latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Bio-Rad Laboratories, Inc. reported revenue of $656.4M and net income of $458.6M. The figures come from its filing with the SEC.

Is Bio-Rad Laboratories, Inc.'s revenue growing?

Revenue in Q3 FY2026 was $656.4M, up 0.5% from $653M in the same quarter a year earlier.

Get an email when BIO reports

Follow BIO and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when BIO files with the SEC.

Source: quarterly figures Bio-Rad Laboratories, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Bio-Rad Laboratories, Inc.